Skip to main content
Erschienen in: Herz 1/2014

01.02.2014 | Original article

Serial evaluation of hepatic function profile after Fontan operation

verfasst von: R. Kaulitz, MD, P. Haber, E. Sturm, J. Schäfer, M. Hofbeck

Erschienen in: Herz | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Moderate persistent elevation of the γ-glutamyltransferase (γGT) level is a frequent finding during long-term follow-up of patients with total cavopulmonary connection (TCPC) for palliation of functionally univentricular hearts. Serial intraindividual data revealed a significant increase in the γGT level within a minimum 4-year interval in more than 80 % of cases. The level of γGT elevation showed a significant correlation to hemodynamic parameters such as systemic ventricular end diastolic pressure and mean pulmonary artery pressure, but did not strongly correlate with duration of follow-up or other liver function parameters, which were less frequent and less impressively deranged. None of the patients had signs of synthetic dysfunction. With increasing postoperative follow-up, abnormalities of sonographic hepatic texture including increased echogenicity, inhomogeneity, or liver surface nodularity were found. All 17 patients with liver surface nodularity had a follow-up period of over 10 years. Structural abnormalities did not correlate with biochemical or hemodynamic parameters. Doppler evaluation revealed inspiratory dependence of hepatic vein flow in more than 90 % as a relevant finding after TCPC; a decrease in portal vein flow velocity was observed in many patients. Since long-term survivors after Fontan procedure are at an increased risk of cardiac hepatopathy and cirrhosis, detailed routine investigation and monitoring of hepatic morphology are needed.
Literatur
1.
Zurück zum Zitat Freedom RM, Hamilton R, Yoo SJ et al (2002) The Fontan procedure: analysis of cohorts and late complications. Cardiol Young 10:307–331 Freedom RM, Hamilton R, Yoo SJ et al (2002) The Fontan procedure: analysis of cohorts and late complications. Cardiol Young 10:307–331
2.
Zurück zum Zitat Kaulitz R, Luhmer I, Bergmann F et al (1997) Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 78:154–159PubMedCentralPubMed Kaulitz R, Luhmer I, Bergmann F et al (1997) Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function. Heart 78:154–159PubMedCentralPubMed
3.
Zurück zum Zitat Stamm C, Friehs I, Mayer JE et al (2001) Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 121:28–41PubMedCrossRef Stamm C, Friehs I, Mayer JE et al (2001) Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 121:28–41PubMedCrossRef
4.
Zurück zum Zitat Tatum GZ, Sigfusson G, Ettedgul JA et al (2006) Pulmonary artery growth fails to match the increase in body surface area after the Fontan operation. Heart 92:511–514PubMedCentralPubMedCrossRef Tatum GZ, Sigfusson G, Ettedgul JA et al (2006) Pulmonary artery growth fails to match the increase in body surface area after the Fontan operation. Heart 92:511–514PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Camposilvan S, Milanesi O, Stellin G et al (2008) Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 86:177–182PubMedCrossRef Camposilvan S, Milanesi O, Stellin G et al (2008) Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg 86:177–182PubMedCrossRef
6.
Zurück zum Zitat Arisawa J, Morimoto S, Ikezoe J et al (1993) Pulsed Doppler echocardiographic assessment of portal venous flow pattern in patients after the Fontan operation. Br Heart J 69:41–46PubMedCentralPubMedCrossRef Arisawa J, Morimoto S, Ikezoe J et al (1993) Pulsed Doppler echocardiographic assessment of portal venous flow pattern in patients after the Fontan operation. Br Heart J 69:41–46PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Hsia T, Khambadkone S, Redington AN et al (2000) Effects of respiration and gravity on infradiaphragmatic venous flow in normal and Fontan patients. Circulation 102:148–153 Hsia T, Khambadkone S, Redington AN et al (2000) Effects of respiration and gravity on infradiaphragmatic venous flow in normal and Fontan patients. Circulation 102:148–153
8.
Zurück zum Zitat Rychik J, Veldtman G, Rand E et al (2012) The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (Epub ahead of print) Rychik J, Veldtman G, Rand E et al (2012) The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (Epub ahead of print)
9.
Zurück zum Zitat Chaloupecky V, Svobodova I, Hadacova I et al (2005) Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart 91:73–79PubMedCentralPubMedCrossRef Chaloupecky V, Svobodova I, Hadacova I et al (2005) Coagulation profile and liver function in 102 patients after total cavopulmonary connection at mid term follow up. Heart 91:73–79PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Ghaferei AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRef Ghaferei AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129:1348–1352CrossRef
12.
Zurück zum Zitat Schwartz MC, Sullivan LM, Glatz AC et al (2012) Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol (Epub ahead of print) Schwartz MC, Sullivan LM, Glatz AC et al (2012) Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol (Epub ahead of print)
13.
Zurück zum Zitat Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160–1174PubMedCrossRef Afdhal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99:1160–1174PubMedCrossRef
14.
Zurück zum Zitat Grigorescu M (2006) Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 15:149–159PubMed Grigorescu M (2006) Noninvasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis 15:149–159PubMed
15.
Zurück zum Zitat Khanna G, Bhalla S, Krishnamurthy R et al (2012) Extracardiac complications of the Fontan circuit. Pediatr Radiol 42:233–241PubMedCrossRef Khanna G, Bhalla S, Krishnamurthy R et al (2012) Extracardiac complications of the Fontan circuit. Pediatr Radiol 42:233–241PubMedCrossRef
16.
Zurück zum Zitat Wu FM, Ukomadu C, Odze RD et al (2011) Liver disease in the patient with Fontan circulation. Congenit Heart Dis 6:190–201PubMedCrossRef Wu FM, Ukomadu C, Odze RD et al (2011) Liver disease in the patient with Fontan circulation. Congenit Heart Dis 6:190–201PubMedCrossRef
17.
Zurück zum Zitat Narkewicz MR, Sondheimer H, Ziegler JW et al (2003) Hepatic function following Fontan procedure. J Pediatr Gastroenterol Nutr 36:352–357PubMedCrossRef Narkewicz MR, Sondheimer H, Ziegler JW et al (2003) Hepatic function following Fontan procedure. J Pediatr Gastroenterol Nutr 36:352–357PubMedCrossRef
18.
Zurück zum Zitat Ambrosy AP, Vaduganathan M, Huffman MD et al (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311PubMedCrossRef Ambrosy AP, Vaduganathan M, Huffman MD et al (2012) Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail 14:302–311PubMedCrossRef
19.
Zurück zum Zitat Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C et al (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical markers. J Thorac Cardiovasc Surg 135:560–567PubMedCrossRef Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C et al (2008) Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical markers. J Thorac Cardiovasc Surg 135:560–567PubMedCrossRef
20.
Zurück zum Zitat Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906PubMedCrossRef Ratziu V, Charlotte F, Heurtier A et al (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128:1898–1906PubMedCrossRef
21.
Zurück zum Zitat Furukawa T, Akimoto K, Ohtsuki M et al (2011) Non-invasive assessment of liver fibrosis in patients after the Fontan operation. Pediatr Int 53:980–984PubMedCrossRef Furukawa T, Akimoto K, Ohtsuki M et al (2011) Non-invasive assessment of liver fibrosis in patients after the Fontan operation. Pediatr Int 53:980–984PubMedCrossRef
22.
Zurück zum Zitat Ewe SH, Tan JL (2009) Hepatocellular carcinoma—a rare complication post Fontan operation. Congenit Heart Dis 4:103–106CrossRef Ewe SH, Tan JL (2009) Hepatocellular carcinoma—a rare complication post Fontan operation. Congenit Heart Dis 4:103–106CrossRef
23.
Zurück zum Zitat Perisic M, Ilic-Mostic T, Stojkovic M et al (2005) Doppler hemodynamic study in portal hypertension and hepatic encephalopathy. Hepatogastroenterology 52:156–160PubMed Perisic M, Ilic-Mostic T, Stojkovic M et al (2005) Doppler hemodynamic study in portal hypertension and hepatic encephalopathy. Hepatogastroenterology 52:156–160PubMed
24.
Zurück zum Zitat Baik SK, Kim JW, Kim HS et al (2006) Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 240:574–580PubMedCrossRef Baik SK, Kim JW, Kim HS et al (2006) Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 240:574–580PubMedCrossRef
Metadaten
Titel
Serial evaluation of hepatic function profile after Fontan operation
verfasst von
R. Kaulitz, MD
P. Haber
E. Sturm
J. Schäfer
M. Hofbeck
Publikationsdatum
01.02.2014
Verlag
Urban & Vogel
Erschienen in
Herz / Ausgabe 1/2014
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-013-3811-5

Weitere Artikel der Ausgabe 1/2014

Herz 1/2014 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.